BRETT K HAUMANN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BRETT K HAUMANN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BRETT K HAUMANN. BRETT K HAUMANN is a Chief Medical Officer in Theravance Biopharma, Inc. ($TBPH) and a SVP Clin Dev & Chief Med Ofc in Theravance Biopharma, Inc. ($TBPH) and a SVP, Clinical Development in Theravance Biopharma, Inc. ($TBPH) and a VP-Clinical Develop. in Theravance Biopharma, Inc. ($TBPH) and a Director in Aimmune Therapeutics, Inc. ($AIMT).
Address: C/O THERAVANCE BIOPHARMA US, INC. 901 GATEWAY BLVD SOUTH SAN FRANCISCO 94080 CA
Companies in which BRETT K HAUMANN is an Insider
Aimmune Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BRETT K HAUMANN: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Oct 14 2020
$AIMT Market Capitalization: $796.78M
$AIMT Previous Close: $18.66
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Theravance Biopharma, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BRETT K HAUMANN: Chief Medical Officer, SVP Clin Dev & Chief Med Ofc, SVP, Clinical Development, VP-Clinical Develop.
Holdings: 307,810 shares
Current Value: $9,418,986
Latest Transaction: Aug 24 2020
$TBPH Market Capitalization: $1.64B
$TBPH Previous Close: $30.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of BRETT K HAUMANN
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 14 2020 | AIMT | Aimmune Therapeuti ... | HAUMANN BRETT K | Director | Option Exercise | D | 17.11 | 25,453 | 435,501 | 0 | |
| Oct 14 2020 | AIMT | Aimmune Therapeuti ... | HAUMANN BRETT K | Director | Sell | D | 34.50 | 13,313 | 459,299 | 0 | 13.3 K to 0 (-100.00 %) |
| Oct 14 2020 | AIMT | Aimmune Therapeuti ... | HAUMANN BRETT K | Director | Sell | U | 34.50 | 6,250 | 215,625 | 0 | 6.3 K to 0 (-100.00 %) |
| Aug 24 2020 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | Chief Medical Offic ... | Sell | S | 18.29 | 25,000 | 457,240 | 282,810 | 307.8 K to 282.8 K (-8.12 %) |
| Aug 24 2020 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | Chief Medical Offic ... | Payment of Exercise | F | 18.22 | 4,646 | 84,650 | 307,810 | 312.5 K to 307.8 K (-1.49 %) |
| May 29 2020 | AIMT | Aimmune Therapeuti ... | HAUMANN BRETT K | Director | Option Exercise | A | 17.11 | 25,453 | 435,501 | 25,453 | |
| May 29 2020 | AIMT | Aimmune Therapeuti ... | HAUMANN BRETT K | Director | Grant | A | 0.00 | 13,313 | 0 | 19,563 | 6.3 K to 19.6 K (+213.01 %) |